search
Back to results

Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial (ISAR-CLOSURE)

Primary Purpose

Coronary Artery Disease

Status
Completed
Phase
Phase 4
Locations
Germany
Study Type
Interventional
Intervention
FemoSeal®
ExoSeal®
Manual compression
Sponsored by
Deutsches Herzzentrum Muenchen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Coronary Artery Disease focused on measuring Closure Device, Coronary Angiography

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient between 18 and 85 years of age
  • Patients undergoing femoral access coronary angiography
  • Access only with 6 F sheath
  • Patient must be competent for providing informed written consent

Exclusion Criteria:

  • Peripheral arterial occlusive disease
  • Prior peripheral artery surgery
  • Percutaneous coronary intervention
  • Femoral access device closure in last 30 days
  • Scheduled Coronary Angiography/Intervention within 90 days
  • Critical limb ischemic
  • Uncontrolled hypertension >220/110 mmHg
  • Coagulopathy (bleeding disorder)
  • Local infection
  • Common femoral artery lumen diameter < 5 mm
  • Allergy to absorbable suture
  • Autoimmune Disease
  • Pregnancy

Sites / Locations

  • Deutsches Herzzentrum Muenchen
  • Klinikum rechts der Isar

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

FemoSeal®

ExoSeal®

Manual compression

Arm Description

Device: FemoSeal®

Device: ExoSeal®

Other: Manual compression

Outcomes

Primary Outcome Measures

Composite of arterial access related complications
Composite of arterial access related complications, defined as the composite of: Rate of ipsilateral groin hematomas with largest diameter exceeding 5 cm Pseudoaneurysm AV-Fistula Major bleeding Critical limb ischemia Local infection Surgical repair Revascularisation

Secondary Outcome Measures

Time to hemostasis, from sheath removal to complete hemostasis
Device deployment failure
Need for repeated manual compression after end of closure procedure
Cost-benefit Analysis

Full Information

First Posted
July 5, 2011
Last Updated
June 8, 2016
Sponsor
Deutsches Herzzentrum Muenchen
search

1. Study Identification

Unique Protocol Identification Number
NCT01389375
Brief Title
Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial
Acronym
ISAR-CLOSURE
Official Title
Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2014
Overall Recruitment Status
Completed
Study Start Date
July 2011 (undefined)
Primary Completion Date
July 2014 (Actual)
Study Completion Date
July 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Deutsches Herzzentrum Muenchen

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Are novel vascular closure devices noninferior to manual compression regarding access site complications after coronary angiography?
Detailed Description
Vascular closure devices have been shown to be safe and effective in reducing the time to hemostasis and immobilization when compared to manual compression following coronary angiography. This effect is beneficial in patients presenting with chronic back pain, prostate enlargement, mental impairment or other disorders that preclude prolonged bed rest. However, adequately powered large scale randomized trials with vascular closure devices remain a gap in the scientific literature. This trial compares, in a randomised design two novel vascular closure devices (FemoSeal & ExoSeal) versus manual compression after coronary angiography. This study is aimed to investigate if novel vascular closure devices are noninferior to manual compression regarding access site complications.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease
Keywords
Closure Device, Coronary Angiography

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
4524 (Actual)

8. Arms, Groups, and Interventions

Arm Title
FemoSeal®
Arm Type
Experimental
Arm Description
Device: FemoSeal®
Arm Title
ExoSeal®
Arm Type
Experimental
Arm Description
Device: ExoSeal®
Arm Title
Manual compression
Arm Type
Active Comparator
Arm Description
Other: Manual compression
Intervention Type
Device
Intervention Name(s)
FemoSeal®
Intervention Description
Closure device for femoral artery access closure
Intervention Type
Device
Intervention Name(s)
ExoSeal®
Intervention Description
Closure device for femoral artery access closure
Intervention Type
Other
Intervention Name(s)
Manual compression
Intervention Description
Conventional manual compression
Primary Outcome Measure Information:
Title
Composite of arterial access related complications
Description
Composite of arterial access related complications, defined as the composite of: Rate of ipsilateral groin hematomas with largest diameter exceeding 5 cm Pseudoaneurysm AV-Fistula Major bleeding Critical limb ischemia Local infection Surgical repair Revascularisation
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Time to hemostasis, from sheath removal to complete hemostasis
Time Frame
30 days
Title
Device deployment failure
Time Frame
30 days
Title
Need for repeated manual compression after end of closure procedure
Time Frame
30 days
Title
Cost-benefit Analysis
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient between 18 and 85 years of age Patients undergoing femoral access coronary angiography Access only with 6 F sheath Patient must be competent for providing informed written consent Exclusion Criteria: Peripheral arterial occlusive disease Prior peripheral artery surgery Percutaneous coronary intervention Femoral access device closure in last 30 days Scheduled Coronary Angiography/Intervention within 90 days Critical limb ischemic Uncontrolled hypertension >220/110 mmHg Coagulopathy (bleeding disorder) Local infection Common femoral artery lumen diameter < 5 mm Allergy to absorbable suture Autoimmune Disease Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maryam Linhardt, MD
Organizational Affiliation
Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Deutsches Herzzentrum Muenchen
City
Munich
ZIP/Postal Code
80636
Country
Germany
Facility Name
Klinikum rechts der Isar
City
Munich
ZIP/Postal Code
81675
Country
Germany

12. IPD Sharing Statement

Citations:
PubMed Identifier
25399273
Citation
Schulz-Schupke S, Helde S, Gewalt S, Ibrahim T, Linhardt M, Haas K, Hoppe K, Bottiger C, Groha P, Bradaric C, Schmidt R, Bott-Flugel L, Ott I, Goedel J, Byrne RA, Schneider S, Burgdorf C, Morath T, Kufner S, Joner M, Cassese S, Hoppmann P, Hengstenberg C, Pache J, Fusaro M, Massberg S, Mehilli J, Schunkert H, Laugwitz KL, Kastrati A; Instrumental Sealing of Arterial Puncture Site-CLOSURE Device vs Manual Compression (ISAR-CLOSURE) Trial Investigators. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial. JAMA. 2014 Nov 19;312(19):1981-7. doi: 10.1001/jama.2014.15305.
Results Reference
background
PubMed Identifier
30354782
Citation
Gewalt SM, Helde SM, Ibrahim T, Mayer K, Schmidt R, Bott-Flugel L, Hoppe K, Ott I, Hieber J, Morath T, Byrne RA, Kufner S, Cassese S, Hoppmann P, Fusaro M, Schunkert H, Laugwitz KL, Kastrati A, Schupke S; Instrumental Sealing of Arterial Puncture Site-CLOSURE Device Versus Manual Compression (ISAR-CLOSURE) Trial Investigators. Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women. Circ Cardiovasc Interv. 2018 Aug;11(8):e006074. doi: 10.1161/CIRCINTERVENTIONS.117.006074.
Results Reference
derived
PubMed Identifier
24952057
Citation
Xhepa E, Byrne RA, Schulz S, Helde S, Gewalt S, Cassese S, Linhardt M, Ibrahim T, Mehilli J, Hoppe K, Grupp K, Kufner S, Bottiger C, Hoppmann P, Burgdorf C, Fusaro M, Ott I, Schneider S, Hengstenberg C, Schunkert H, Laugwitz KL, Kastrati A; ISAR-CLOSURE investigators. Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: the Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial. EuroIntervention. 2014 Jun;10(2):198-203. doi: 10.4244/EIJV10I2A33.
Results Reference
derived

Learn more about this trial

Instrumental Sealing of Arterial Puncture Site Closure Device Versus Manual Compression Trial

We'll reach out to this number within 24 hrs